glutathione and chemotherapy drugs Glutathione-mediated nanomedicines for cancer diagnosis therapy LKB1 loss is associated with
LKB1 loss is associated with glutathione deficiency under oxidative stress and sensitivity of cancer cells to cytotoxic drugs and irradiation ScienceDirect Glutathione activated prodrug based self delivering nanomedicines for tumoricidal chemo photodynamic synergistic therapy ScienceDirect A pH glutathione dual responsive drug loaded heterostructure nanozyme for synergistic chemotherapy chemodynamic therapy against melanoma ScienceDirect Frontiers Glutathione responsive and exhausting metal nanomedicines for robust synergistic cancer therapy Glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics Discover Oncology Springer Nature Link Glutathione: Lights and Shadows in Cancer Patients
Pay in 4 interest-free payments of $7.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3





